JURA Bio, Inc.
PrivateLast Round
Seed
Sep 21, 2023
Total Funding Raised
$16.21M
Company Overview
JURA Bio, Inc. is a preclinical biotechnology company that develops immune-based therapeutics for autoimmune diseases and oncology. The company's platform integrates generative machine learning and synthetic biology to discover and develop genetic medicines. It focuses on creating a map from any antigen-HLA pair to any T cell receptor, which would significantly advance the development of therapies. JURA Bio is developing allogeneic, off-the-shelf CAR-T cells, with an initial focus on progressive forms of multiple sclerosis. The company was co-founded in 2017 by Elizabeth Wood, Julie Norville, and George Church.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
JURA Bio, Inc. Comps
Public and private peers based on sector, stage, and business model.
JURA Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 21, 2023 | ||||
| Grant | Dec 22, 2022 |
JURA Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LabCentral Ignite | Grant |
| Massachusetts Life Sciences Center | Grant |
| Mintz | Grant |
| Fontus Capital | Seed |
JURA Bio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about JURA Bio, Inc.'s valuation, stock price, and market status.